How To Get Involved
Partner With Us
It's never too early to get involved! Based on your objectives, we can create bespoke packages designed specifically for you.
From presenting your expertize on the main stage to hosting the infamous CAR-T Party. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
Discuss your objectives with Oleksiy Ihnatenko, Commercial Partnerships Manager; [email protected].
OR REGISTER YOUR INTEREST IN SPONSORSHIP HERE.
Register As A Delegate
WHO WILL BE THERE
Network with industry experts from:
- Senior-level leaders from biotech and representatives from big pharma
- Academic experts in cell therapy
- Process standardisation - technology/services
- Logistics companies - cell storage/transport
- Service providers – CROs, CDMOs, consultants, logistics companies and more
"New research was presented. The panels were educational and the small intimate setting was a plus."
TCR2 Therapeutics (Previous OCTS Attendee)
Last year's attendees included:
Previous Speakers
John Langowski
Peter Bross
Crystal L Mackall MD
Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine
Director, Stanford Center for Cancer Cell Therapy
Director, Parker Institute for Cancer Immunotherapy at Stanford
Co-Executive Director, Stanford Laboratory for Cell and Gene Medicine
Associate Director, Stanford Cancer Institute
Arun Balakumaran
Vered Caplan
Birgit Schultes
Snehal Patel
Snehal Patel is the Global Head and Vice President for Cell Therapy Manufacturing for Bristol Myers Squibb (BMS). He leads the growing global manufacturing network to produce Clinical and Commercial Cell Therapy Products, including the two cell therapies recently launched in 2021 by BMS. Overseeing three state-of-the-art production facilities, Snehal is also closely involved in planning, development and construction of two additional facilities to continue expanding BMS’ global footprint. In addition, he has served as Site Head for Cell Therapy Manufacturing and is based in Seattle, WA. He started at BMS via the Juno Therapeutics acquisition in February 2018.
Prior to joining BMS, Snehal worked at Genentech/Roche for ~18 years, holding a variety of different roles with increasing responsibility, including Head of Global External Drug Product Manufacturing, Head of Drug Product Operations, and Head of Quality Operations.
Snehal has a breadth of knowledge and experience including leadership roles in Technical Operations, Technology, Training, and Quality Assurance in Biologics, Small Molecules, and Cell Therapy. He is routinely sought out for his technical expertise, as well as his ability to collaborate and influence. He is a dynamic leader where he focuses on Inspirational Leadership and Development of his team.
Serena De Vita
Debora Barton, MD
Kate Rochlin
Christopher Pastorello
Robbie Majzner
Eric Halioua
Cheng Liu
Carnley Norman
Austin Boesch
Christian Hinrichs
Stefanie Bailey
Michael Leek
Paul Rennert
Guanglin Yu
Adham Bear
Moonsoo Jin
Mark Yarmarkovich
Jorge Mansilla-Soto
John Lu
Branden Moriarity
Jan ter Meulen
Gavin MacBeath
Alba Gonzalez
Amanda Conerty
David Brochu
Jeffrey S Miller
Jennifer Buell
Lucas de Breed
Matthew Li
Gail Turner
Melissa Sebok
Reagan Jarvis
Markus Gruell
Robert Tighe
Christina Bailey
Laura Johnson
Steven Doares
Pete Smith
Breanna DiAndreth
Subhadra Jayaraman
Lucia Poncette
Lucia is T-knife‘s Director TCR discovery and is one of its founding scientists. She studied Human Biology in Marburg and Toowoomba (Australia) and obtained a doctor’s degree in tumor immunology from the Free University of Berlin followed by a PostDoc at the Max Delbrück Center for Molecular Medicine in Berlin. For the last 10 years Lucia has studied T cell receptors and their application in the treatment of cancer. At T-knife Lucia oversees the early development and characterization of T cell receptors using T-knife‘s proprietary myT platform.
Stefania Gobessi
Raymond Luke
Vineet Kacker
Ashish Kothari
Nissim Darvish
David Moskowitz
Ansbert Gadicke
Philip Lee
Jennifer McDevitt
David Ferrick
Brian Newsom
Jens Eberlein
Register Your Interest
The agenda for the Onco Cell Therapy Summit 2023 will be released very soon.
Fill out this form to register your interest and be the first to recieve the agenda when it becomes available!
REGISTER YOUR INTEREST
Mission Statement
The World Oncology Cell Therapy Congress (April 2023) USA is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.
Demonstrating the value of innovative cell therapy products and securing access for patients is a key priority for all developers. In 2023, the World OCT Summit will become the only industry forum to add an exclusive pre-event evening networking session for clinicians looking to overcome barriers to patient access and facilitate clinical distribution of transformative cell therapy products. The congress will also redefine industry networking, with every attendee incentivised to complete a profile, enabling everyone to find and touch base with the pioneers and companies they would like to meet.
The congress schedule will also be revamped and be repositioned to reflect the dynamic research environment of the cell therapy field. Our on-stage talks, panels and Q&As will come under the following themes – ‘Breakthroughs and Pipeline Advancements’, ‘New Cell Therapy Platforms and Enabling Technologies’, ‘Manufacturing at Scale and Commercialization’ – and with our pre-event evening expanding into ‘Cell Therapy Access and Clinical Trial Delivery’.
Previous Partners
Gold Partners
Event Partners
Barrington James
Website: https://barringtonjames.com/
Please visit our website for more information.
Non-Profit Partner
Alliance for Cancer Gene Therapy
Website: https://acgtfoundation.org/groundbreaking-research/what-were-working-on/
Please join the Alliance for Cancer Gene Therapy in turning transformative ideas into life-saving therapies. For 20 years, we have backed innovative scientists in creating pioneering treatments with life-saving results.
ACGT is the only public charity dedicated exclusively to cancer cell and gene therapy research. 100% of all public donations go directly to researchers, vetted and chosen by ACGT’s esteemed Scientific Advisory Council.
https://acgtfoundation.org/donate/
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. From presenting your expertize on the main stage to hosting the infamous CAR-T Party. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
Discuss your objectives with James Tappenden, Sales Director; [email protected] or Oleksiy Ihnatenko, Commercial Partnerships; [email protected].
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact Laura Hobson, Senior Marketing Manager; [email protected]
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Ticket price will increase in
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 5% Off
Book a Team of 5+ - Save an Additional 10% Off
Book a Team of 10+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Terms & Conditions
In the event that Kisaco Research postpones an event for any reason or changes the event format to ‘virtual event’, any in-person registrations for this event will be automatically transferred to the virtual registration package. The delegate will receive a credit note for the difference in ticket value from the fee paid. You may use this credit for another Kisaco Research event to be mutually agreed with Kisaco Research, which must occur within 12 months from the date of the event which the delegate had originally registered for.
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.